Skip to content
cccskills
FreePublished on GitHub

ata-random-cortisol-ai-against

Recommends against using a random cortisol level to diagnose adrenal insufficiency. Triggers when considering a random cortisol test for AI evaluation (e.g., "random cortisol measurement being considered for AI diagnosis").

The English summary is being prepared. Showing the original description.

See how to install

Files included (1)

  • SKILL.md2.0 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Recommend against random cortisol level for AI diagnosis

STEP 1 — Gather Information

Collect clinical signs/symptoms suggestive of adrenal insufficiency (fatigue, hypotension, hyponatremia, hyperkalemia), review timing of last glucocorticoid dose, and note if a random cortisol test is under consideration.

STEP 2 — Rule In / Rule Out

If a random cortisol level is being considered for AI diagnosis, recommend against its use and proceed to obtain an 8–9 AM serum cortisol level; otherwise, proceed with appropriate diagnostic pathway.

STEP 3 — Classify or Stratify

Interpret the 8–9 AM cortisol: <3 µg/dL suggests AI; >15 µg/dL makes AI unlikely; values between 3–15 µg/dL require an ACTH stimulation test.

STEP 4 — Decide

If cortisol <3 µg/dL, diagnose AI and initiate glucocorticoid replacement; if >15 µg/dL, pursue alternative diagnoses; if 3–15 µg/dL, perform ACTH stim test and diagnose AI if peak cortisol ≤18.1 µg/dL (500 nmol/L).

Clinical Guardrails / Mimics / Pitfalls

Do not rely on random cortisol due to circadian variation, estrogen-induced CBG elevation, and glucocorticoid interference; ensure patient is off exogenous glucocorticoids for adequate washout before testing; ACTH stimulation test remains the diagnostic standard when morning cortisol is indeterminate.

Concrete Clinical Example

A 50‑year‑old woman presents with fatigue and hyponatremia; a random cortisol at 14:00 is considered. Instead, an 8 AM cortisol returns 2.5 µg/dL (<3), prompting an ACTH stim test with peak cortisol 10 µg/dL (<18.1), confirming AI; hydrocortisone 15–20 mg daily is started.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill